| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
| 2015 | Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile | Percival, M. E. M.; Medeiros, B. C.; Tian, L.; Robeson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Bone Marrow Transplantation | | | |
| 2015 | Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms | Narayan, R.; Benjamin, J.; Laport, G.; Tian, L.; Tate, K.; Elder, L.; Galvez, L.; Armstrong, R.; Sheehan, K.; Lowsky, R.; Arai, S.; Johnston, L.; Miklos, D.; Muffly, L. S.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Strober, S.; Negrin, R.; Meyer, E. | Blood | | | |
| 2014 | European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation | Medeiros, B. C.; Tian, L.; Robenson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Blood Cancer Journal | | | |
